Cargando…
A small-molecule TLR4 antagonist reduced neuroinflammation in female E4FAD mice
BACKGROUND: APOE genotype is the greatest genetic risk factor for sporadic Alzheimer’s disease (AD). APOE4 increases AD risk up to 12-fold compared to APOE3, an effect that is greater in females. Evidence suggests that one-way APOE could modulate AD risk and progression through neuroinflammation. In...
Autores principales: | Balu, Deebika, Valencia-Olvera, Ana C., Nguyen, Austin, Patnam, Mehul, York, Jason, Peri, Francesco, Neumann, Frank, LaDu, Mary Jo, Tai, Leon M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585767/ https://www.ncbi.nlm.nih.gov/pubmed/37858252 http://dx.doi.org/10.1186/s13195-023-01330-6 |
Ejemplares similares
-
APOE genotype and sex modulate Alzheimer’s disease pathology in aged EFAD transgenic mice
por: Balu, Deebika, et al.
Publicado: (2023) -
Inhibition of ACAT as a Therapeutic Target for Alzheimer’s Disease Is Independent of ApoE4 Lipidation
por: Valencia-Olvera, Ana C., et al.
Publicado: (2023) -
Synthetic glycolipid-based TLR4 antagonists negatively regulate TRIF-dependent TLR4 signalling in human macrophages
por: Palmer, Charys, et al.
Publicado: (2021) -
The synthetic glycolipid-based TLR4 antagonist FP7 negatively
regulates in vitro and in vivo haematopoietic
and non-haematopoietic vascular TLR4 signalling
por: Palmer, Charys, et al.
Publicado: (2018) -
Increasing the Chemical Variety of Small-Molecule-Based TLR4 Modulators: An Overview
por: Romerio, Alessio, et al.
Publicado: (2020)